SHINE Technologies LLC will begin ramping up production of its medical isotopes next year as it plans to increase cost effectiveness to eventually move its fusion technology into the recycling of nuclear waste and the fusion energy fields, CEO Greg Piefer said at the Wisconsin Entrepreneurs’ Conference Thursday.
Janesville-based SHINE is currently working in its phase two of company development where it produces medical isotopes using small-scale nuclear transmutation, which converts one element into another. Medical isotopes have historically been produced in nuclear reactors that produce waste lasting thousands or millions of years, Piefer said at the conference.
